Phase 2 Readout
QNCX: Phase 2 Readout: lam-001
December 31, 2026 · lam-001. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Quince Therapeutics, Inc. (QNCX)
- Drug
- lam-001
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: lam-001
- Drug
- lam-001
- Indication
- bronchiolitis obliterans syndrome post lung transplant (BOS)